SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $56,000 | -91.8% | 14,000 | -84.8% | 0.00% | -88.9% |
Q4 2021 | $679,000 | +928.8% | 92,082 | +752.6% | 0.02% | +350.0% |
Q1 2021 | $66,000 | -95.1% | 10,800 | -89.2% | 0.00% | -89.7% |
Q4 2020 | $1,349,000 | +653.6% | 100,152 | -23.8% | 0.04% | +333.3% |
Q3 2020 | $179,000 | -44.9% | 131,400 | +22.1% | 0.01% | -50.0% |
Q2 2020 | $325,000 | -58.8% | 107,600 | -37.4% | 0.02% | -58.1% |
Q4 2019 | $788,000 | -89.0% | 171,800 | -21.4% | 0.04% | -92.6% |
Q3 2019 | $7,164,000 | +356.0% | 218,462 | +93.0% | 0.58% | +386.7% |
Q2 2019 | $1,571,000 | +583.0% | 113,200 | +577.8% | 0.12% | +500.0% |
Q1 2019 | $230,000 | -13.9% | 16,700 | -82.9% | 0.02% | +17.6% |
Q4 2018 | $267,000 | +69.0% | 97,700 | +289.2% | 0.02% | +112.5% |
Q2 2018 | $158,000 | -85.0% | 25,100 | -56.0% | 0.01% | -84.9% |
Q1 2018 | $1,050,000 | +1079.8% | 57,100 | -78.5% | 0.05% | +1225.0% |
Q4 2017 | $89,000 | -74.2% | 265,900 | +99.0% | 0.00% | -75.0% |
Q3 2017 | $345,000 | +80.6% | 133,600 | +120.8% | 0.02% | +60.0% |
Q2 2017 | $191,000 | -91.0% | 60,500 | -88.1% | 0.01% | -92.4% |
Q1 2017 | $2,113,000 | – | 509,700 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |